Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice

NYL Pang, ASR Pang, VT Chow, DY Wang - Military Medical Research, 2021 - Springer
SARS-CoV-2 is a newly identified member of the coronavirus family that has caused the
Coronavirus disease 2019 (COVID-19) pandemic. This rapidly evolving and unrelenting …

Overview of neutralizing antibodies and their potential in COVID-19

JJ Morales-Núñez, JF Muñoz-Valle… - Vaccines, 2021 - mdpi.com
The antibody response to respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a
major focus of COVID-19 research due to its clinical relevance and importance in vaccine …

Oxidative stress status in COVID-19 patients hospitalized in intensive care unit for severe pneumonia. A pilot study

J Pincemail, E Cavalier, C Charlier, JP Cheramy–Bien… - Antioxidants, 2021 - mdpi.com
Background: A key role of oxidative stress has been highlighted in the pathogenesis of
COVID-19. However, little has been said about oxidative stress status (OSS) of COVID-19 …

COVID‐19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS‐CoV‐2

NL Stute, JL Stickford, VM Province… - The Journal of …, 2021 - Wiley Online Library
Key points The impact of SARS‐CoV‐2 infection on autonomic and cardiovascular function
in otherwise healthy individuals is unknown. For the first time it is shown that young adults …

ECMO in COVID-19—prolonged therapy needed? A retrospective analysis of outcome and prognostic factors

E Dreier, MV Malfertheiner, T Dienemann… - …, 2021 - journals.sagepub.com
Background: The role of venovenous extracorporeal membrane oxygenation (VV ECMO) in
patients with COVID-19-induced acute respiratory distress syndrome (ARDS) still remains …

Identification of parameters representative of immune dysfunction in patients with severe and fatal COVID-19 infection: a systematic review and meta-analysis

R Qin, L He, Z Yang, N Jia, R Chen, J Xie, W Fu… - Clinical Reviews in …, 2023 - Springer
Abnormal immunological indicators associated with disease severity and mortality in
patients with COVID-19 have been reported in several observational studies. However …

Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents

B Sánchez-Sendra, E Albert, J Zulaica, I Torres… - Scientific Reports, 2022 - nature.com
Immunosenescence may impact the functionality and breadth of vaccine-elicited humoral
immune responses. The ability of sera to neutralize the SARS-CoV-2 spike protein (S) from …

Anti–SARS-CoV-2 antibody responses in convalescent plasma donors are increased in hospitalized patients; subanalyses of a phase 2 clinical study

E Terpos, M Politou, TN Sergentanis, A Mentis… - Microorganisms, 2020 - mdpi.com
We evaluated the antibody responses in 259 potential convalescent plasma donors for
Covid-19 patients. Different assays were used: a commercial ELISA detecting antibodies …

Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent …

A Valdivia, I Torres, V Latorre… - European Journal of …, 2021 - Springer
Whether antibody levels measured by commercially available enzyme or chemiluminescent
immunoassays targeting the SARS-CoV-2 spike (S) protein can act as a proxy for serum …

Label-free electrochemical immunosensor employing new redox probes/porous organic polymers/graphene oxide nanocomposite towards multiplex detection of three …

P Yaiwong, S Wiratchan, N Semakul… - Materials Today …, 2024 - Elsevier
Since an outbreak of severe acute respiratory disease caused by coronavirus 2 (SARS-CoV-
2) in the province of Wuhan, China, coronavirus disease 2019 (COVID-19) has …